Cargando…

Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods

BACKGROUND AND OBJECTIVE: The new type of Coronavirus (2019-nCov) epidemic spread rapidly, causing more than 250 thousand deaths worldwide. The virus, which first appeared as a sign of pneumonia, was later called the SARS-COV-2 with Severe Acute Respiratory Syndrome by the World Health Organization....

Descripción completa

Detalles Bibliográficos
Autores principales: Kivrak, Mehmet, Guldogan, Emek, Colak, Cemil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826038/
https://www.ncbi.nlm.nih.gov/pubmed/33513487
http://dx.doi.org/10.1016/j.cmpb.2021.105951
_version_ 1783640446822514688
author Kivrak, Mehmet
Guldogan, Emek
Colak, Cemil
author_facet Kivrak, Mehmet
Guldogan, Emek
Colak, Cemil
author_sort Kivrak, Mehmet
collection PubMed
description BACKGROUND AND OBJECTIVE: The new type of Coronavirus (2019-nCov) epidemic spread rapidly, causing more than 250 thousand deaths worldwide. The virus, which first appeared as a sign of pneumonia, was later called the SARS-COV-2 with Severe Acute Respiratory Syndrome by the World Health Organization. The SARS-COV-2 virus is triggered by binding to the Angiotensin-Converting Enzyme 2 (ACE 2) inhibitor, which is vital in cardiovascular diseases and the immune system, especially in conditions such as cerebrovascular, hypertension, and diabetes. This study aims to evaluate the prediction performance of death status based on the demographic/clinical factors (including COVID-19 severity) by data mining methods. METHODS: The dataset consists of 1603 SARS-COV-2 patients and 13 variables obtained from an open-source web address. The current dataset contains age, gender, chronic disease (hypertension, diabetes, renal, cardiovascular, etc.), some enzymes (ACE, angiotensin II receptor blockers), and COVID-19 severity, which are used to predict death status using deep learning and machine learning approaches (random forest, k-nearest neighbor, extreme gradient boosting [XGBoost]). A grid search algorithm tunes hyperparameters of the models, and predictions are assessed through performance metrics. Steps of knowledge discovery in databases are applied to obtain the relevant information. RESULTS: The accuracy rate of deep learning (97.15%) was more successful than the accuracy rate based on classical machine learning (92.15% for RF and 93.4% for k-NN), but the ensemble classifier XGBoost method gave the highest accuracy (99.7%). While COVID-19 severity and age calculated from XGBoost were the two most important factors associated with death status, the most determining variables for death status estimated from deep learning were COVID-19 severity and hypertension. CONCLUSIONS: The proposed model (XGBoost) achieved the best prediction of death status based on the factors as compared to the other algorithms. The results of this study can guide patients with certain variables to take early measures and access preventive health care services before they become infected with the virus.
format Online
Article
Text
id pubmed-7826038
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-78260382021-01-25 Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods Kivrak, Mehmet Guldogan, Emek Colak, Cemil Comput Methods Programs Biomed Article BACKGROUND AND OBJECTIVE: The new type of Coronavirus (2019-nCov) epidemic spread rapidly, causing more than 250 thousand deaths worldwide. The virus, which first appeared as a sign of pneumonia, was later called the SARS-COV-2 with Severe Acute Respiratory Syndrome by the World Health Organization. The SARS-COV-2 virus is triggered by binding to the Angiotensin-Converting Enzyme 2 (ACE 2) inhibitor, which is vital in cardiovascular diseases and the immune system, especially in conditions such as cerebrovascular, hypertension, and diabetes. This study aims to evaluate the prediction performance of death status based on the demographic/clinical factors (including COVID-19 severity) by data mining methods. METHODS: The dataset consists of 1603 SARS-COV-2 patients and 13 variables obtained from an open-source web address. The current dataset contains age, gender, chronic disease (hypertension, diabetes, renal, cardiovascular, etc.), some enzymes (ACE, angiotensin II receptor blockers), and COVID-19 severity, which are used to predict death status using deep learning and machine learning approaches (random forest, k-nearest neighbor, extreme gradient boosting [XGBoost]). A grid search algorithm tunes hyperparameters of the models, and predictions are assessed through performance metrics. Steps of knowledge discovery in databases are applied to obtain the relevant information. RESULTS: The accuracy rate of deep learning (97.15%) was more successful than the accuracy rate based on classical machine learning (92.15% for RF and 93.4% for k-NN), but the ensemble classifier XGBoost method gave the highest accuracy (99.7%). While COVID-19 severity and age calculated from XGBoost were the two most important factors associated with death status, the most determining variables for death status estimated from deep learning were COVID-19 severity and hypertension. CONCLUSIONS: The proposed model (XGBoost) achieved the best prediction of death status based on the factors as compared to the other algorithms. The results of this study can guide patients with certain variables to take early measures and access preventive health care services before they become infected with the virus. Elsevier B.V. 2021-04 2021-01-22 /pmc/articles/PMC7826038/ /pubmed/33513487 http://dx.doi.org/10.1016/j.cmpb.2021.105951 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kivrak, Mehmet
Guldogan, Emek
Colak, Cemil
Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods
title Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods
title_full Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods
title_fullStr Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods
title_full_unstemmed Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods
title_short Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods
title_sort prediction of death status on the course of treatment in sars-cov-2 patients with deep learning and machine learning methods
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826038/
https://www.ncbi.nlm.nih.gov/pubmed/33513487
http://dx.doi.org/10.1016/j.cmpb.2021.105951
work_keys_str_mv AT kivrakmehmet predictionofdeathstatusonthecourseoftreatmentinsarscov2patientswithdeeplearningandmachinelearningmethods
AT guldoganemek predictionofdeathstatusonthecourseoftreatmentinsarscov2patientswithdeeplearningandmachinelearningmethods
AT colakcemil predictionofdeathstatusonthecourseoftreatmentinsarscov2patientswithdeeplearningandmachinelearningmethods